OMER · Omeros Corp
United States · RS rating 98 · As of 2026-10-14
| Price | 18.43 USD |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 92 / 97 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 56 / 54 / 71 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +308.5% |
| Sales growth Q/Q | +188.4% |
| Distance from 52-week high | +12.4% |
| Market cap (USD) | $973.4M |